4D Molecular Therapeutics(FDMT)
$12.99+0.53 (+4.25%)
FDMT
4D Molecular Therapeutics financials statements
$12.99
At close:+0.53 (+4.25%)
Want to see FDMT full AI Analyst Report?
4D Molecular Therapeutics (FDMT) Income Statement
534 Followers
4D Molecular Therapeutics Income Statement
Last quarter (Q2 2026), 4D Molecular Therapeutics's total revenue was $3.78M, an increase of 25106.67% from the same quarter last year. In Q2, 4D Molecular Therapeutics's net income was $-72.94M. See 4D Molecular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 85.21M | $ 37.00K | $ 20.72M | $ 3.13M | $ 18.04M | |
| $ 77.58M | $ -141.26M | $ -76.37M | $ -77.12M | $ -43.32M | |
| $ 237.13M | $ 46.58M | $ 36.49M | $ 32.91M | $ 28.01M | |
| Depreciation and Amortization | $ 7.63M | $ 6.71M | $ 5.75M | $ 3.88M | $ 3.02M |
| $ -132.48M | $ -154.16M | $ -95.09M | $ -103.61M | $ -68.30M | |
| $ -159.55M | $ -187.84M | $ -112.87M | $ -110.03M | $ -71.33M | |
| $ 19.44M | $ 26.97M | $ 12.03M | $ 2.54M | $ 16.00K | |
| $ -140.11M | $ -160.87M | $ -100.84M | $ -107.49M | $ -71.32M | |
| $ -140.11M | $ -160.87M | $ -100.84M | $ -107.49M | $ -71.32M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.42 | $ -2.98 | $ -2.58 | $ -3.12 | $ -2.46 |
| Diluted EPS | $ -2.42 | $ -2.98 | $ -2.58 | $ -3.12 | $ -2.46 |
| Weighted Average Shares Outstanding | 57.93M | 53.94M | 39.13M | 32.35M | 27.73M |
| Weighted Average Shares Outstanding (Diluted) | 57.93M | 53.94M | 39.13M | 32.35M | 27.73M |
Currency in USD
